Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients (Q46160352)
Jump to navigation
Jump to search
scientific article published on 17 January 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients |
scientific article published on 17 January 2009 |
Statements
1 reference
Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients (English)
1 reference
Katsuto Takenaka
1 reference
Tetsuya Eto
1 reference
Koji Nagafuji
1 reference
Kenjiro Kamezaki
1 reference
Yayoi Matsuo
1 reference
Goichi Yoshimoto
1 reference
Naoki Harada
1 reference
Maki Yoshida
1 reference
Hideho Henzan
1 reference
Ken Takase
1 reference
Toshihiro Miyamoto
1 reference
Koichi Akashi
1 reference
Mine Harada
1 reference
Takanori Teshima
1 reference
Fukuoka Blood and Marrow Transplant Group (FBMTG)
1 reference
17 January 2009
1 reference
89
1 reference
2
1 reference
231-237
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference